Understanding payer strategies for controlling market access
Market access is one of the hottest topics and greatest concerns in the pharma industry today.
Market access is one of the hottest topics and greatest concerns in the pharma industry today. And understanding payer strategies for controlling market access is critical for pharma companies seeking to gain access, optimize pricing and get to peak sales as quickly as possible.
Alan Cassels, a drug policy researcher at the University of Victoria in Canada, spoke recently with eyeforpharma about the main issues around market access in Canada, including roadblocks created by government and how pharmas can prepare for increasingly complex healthcare systems.